QA: Protea Biosciences Group Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335103_2017_Protea_Biosciences_Group_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335103, Protea Biosciences Group Inc

  xvar xval
0 AssetsCurrent 728,924
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,466,125
3 remainder_Assets 19,041
4 LiabilitiesCurrent 15,550,489
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,445,786
8 SellingGeneralAndAdministrativeExpense 5,567,232
9 ResearchAndDevelopmentExpense 706,587
10 remainder_Expenses 0
11 remainder_Revenues 2,985,710
12 remainder_NetIncome -48,706,942
13 remainder_ComprehensiveNetIncome 256
  yvar yval
0 Assets 3,214,090
1 Liabilities 15,550,489
2 Expenses 7,719,605
3 Revenues 2,985,710
4 StockholdersEquity -12,336,399
5 NetIncome -53,440,837
6 ComprehensiveNetIncome -53,440,709
7 BaseVar 39,088,546
8 EconomicCapitalRatiobeforeLimitedLiability -8.56
9 EconomicCapitalRatio 0.00400

Edgar->Model Mapping

Feature Distribution

Change over Time